Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
Therapies based on immune checkpoint inhibitors (ICPI) have yielded promising albeit limited results in patients with hepatocellular carcinoma (HCC). Vaccines have been proposed as combination partners to enhance response rates to ICPI. Thus, we analyzed the combined effect of a vaccine based on the...
Main Authors: | Leyre Silva, Josune Egea, Lorea Villanueva, Marta Ruiz, Diana Llopiz, David Repáraz, Belén Aparicio, Aritz Lasarte-Cia, Juan José Lasarte, Marina Ruiz de Galarreta, Amaia Lujambio, Bruno Sangro, Pablo Sarobe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3397 |
Similar Items
-
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
by: David Repáraz, et al.
Published: (2022-02-01) -
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
by: David Repáraz, et al.
Published: (2022-10-01) -
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
by: Belén Aparicio, et al.
Published: (2023-01-01) -
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
by: Belén Aparicio, et al.
Published: (2023-03-01) -
Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
by: Wanying Shen, et al.
Published: (2022-10-01)